| __timestamp | Cytokinetics, Incorporated | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 44426000 | 9216000000 |
| Thursday, January 1, 2015 | 46398000 | 8296000000 |
| Friday, January 1, 2016 | 59897000 | 10044000000 |
| Sunday, January 1, 2017 | 90296000 | 11560000000 |
| Monday, January 1, 2018 | 89135000 | 10558000000 |
| Tuesday, January 1, 2019 | 86125000 | 9351000000 |
| Wednesday, January 1, 2020 | 96951000 | 8933000000 |
| Friday, January 1, 2021 | 159938000 | 8284000000 |
| Saturday, January 1, 2022 | 240813000 | 7952000000 |
| Sunday, January 1, 2023 | 330123000 | 8200000000 |
| Monday, January 1, 2024 | 8480000000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, understanding cost structures is crucial. Teva Pharmaceutical Industries Limited, a global leader, and Cytokinetics, Incorporated, a pioneering biotech firm, offer a fascinating contrast in their cost of revenue trends from 2014 to 2023.
Teva's cost of revenue has shown a consistent pattern, averaging around $9.2 billion annually. Despite fluctuations, the company maintained a robust cost structure, peaking in 2017 with a 25% increase from 2014. However, a gradual decline followed, reaching its lowest in 2022.
Cytokinetics, on the other hand, experienced a dramatic rise. Starting at $44 million in 2014, their costs surged by over 640% by 2023. This growth reflects their aggressive expansion and investment in innovative therapies.
This comparison highlights the diverse strategies and market positions of these two industry players.
AstraZeneca PLC vs Cytokinetics, Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Pfizer Inc. vs Cytokinetics, Incorporated
Cost of Revenue Trends: Bristol-Myers Squibb Company vs Teva Pharmaceutical Industries Limited
GSK plc vs Cytokinetics, Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Pharming Group N.V.
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Veracyte, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down United Therapeutics Corporation and Cytokinetics, Incorporated's Expenses
Cost of Revenue Comparison: Incyte Corporation vs Cytokinetics, Incorporated
Comparing Cost of Revenue Efficiency: Sarepta Therapeutics, Inc. vs Cytokinetics, Incorporated
Cytokinetics, Incorporated vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored